-
Mentored Career Development Program (K01) for Early Stage Investigators Using Nonhuman Primate Research Models (K01 Independent Clinical Trial Not Allowed)
(PAR-20-258)
National Institute of Allergy and Infectious Diseases
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Center for Complementary and Integrative Health
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Application Receipt Date(s): Standard dates apply.
The first standard due date for this FOA is October 12, 2020.
Alltypes of non-AIDS applicationsallowed for this funding opportunity announcement are due on these dates.
-
New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Trial Required)
(PAR-20-273)
National Institute on Drug Abuse
Application Receipt Date(s): Only accepting applications for the AIDS Application Due dates listed below
-
New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 - Clinical Trial Optional )
(PAR-20-274)
National Institute on Drug Abuse
Application Receipt Date(s): Only accepting applications for the AIDS Application Due Dates listed below.
-
NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)
(PAR-20-287)
National Cancer Institute
Application Receipt Date(s): January 4, 2021
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s)
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)
(PAR-20-288)
National Cancer Institute
Application Receipt Date(s): January 4, 2021
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s)
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
(PAR-20-292)
National Cancer Institute
Application Receipt Date(s): October 20, 2020; February 19, 2021; June 21, 2021; October 20, 2021; February 22, 2022; June 21, 2022
-
Clinical Translation of Activated Optical Fluorescence Methods and Technologies for Sensitive Cancer Detection in Vivo (R01 Clinical Trial Optional)
(PAR-20-295)
National Cancer Institute
Application Receipt Date(s): February 10, 2021; October 13, 2021
-
NIOSH Centers of Excellence for Total Worker Health (U19)
(PAR-20-297)
National Institute for Occupational Safety and Health
Application Receipt Date(s): February 3, 2021; October 29, 2021; October 28, 2022; October 30, 2023
No late applications will be accepted for this FOA
-
NCI Pediatric In Vivo Testing Program (U01 Clinical Trial Not Allowed)
(RFA-CA-20-034)
National Cancer Institute
Application Receipt Date(s): November 09, 2020
No late applications will be accepted for this Funding Opportunity Announcement.
-
NCI Pediatric In Vivo Testing Program Coordinating Center (U24 Clinical Trial Not Allowed)
(RFA-CA-20-041)
National Cancer Institute
Application Receipt Date(s): November 9, 2020
-
Glioblastoma Therapeutics Network (U19 Clinical Trial Required)
(RFA-CA-20-047)
National Cancer Institute
Application Receipt Date(s): November 19, 2020
No late applications will be accepted for this Funding Opportunity Announcement.
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00)
(RFA-CA-20-048)
National Cancer Institute
Application Receipt Date(s): November 18, 2020
All applications are due, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
No late applications will be accepted for this FOA.
-
Toward ElucidAting MechanismS of HIV Pathogenesis within the Mission of the NIDDK (Pathogenesis TEAMS) (R01 Clinical Trial Optional)
(RFA-DK-20-022)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
-
RESolution of InflammaTion in EnvirOnmentally Related diseasE (RESTORE) (R01 Clinical Trial Not Allowed)
(RFA-ES-20-013)
National Institute of Environmental Health Sciences
Application Receipt Date(s): February 11, 2021
-
Center without Walls for Molecular Mechanisms of Neurodegeneration in Frontotemporal Degeneration (FTD) (U54 Clinical Trial not Allowed)
(RFA-NS-21-003)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
Application Receipt Date(s): November 2, 2020
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Multi-disciplinary Machine-assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey (UG3/UH3 Clinical Trial Not Allowed)
(RFA-TR-20-030)
National Center for Advancing Translational Sciences
National Center for Advancing Translational Sciences
Application Receipt Date(s): November 12, 2020